Molecular and physicochemical aspects of the interactions of the tuberculostatics ofloxacin and rifampicin with liposomal bilayers: A 31P- NMR and DSC study

Colloids and Surfaces A: Physicochemical and Engineering Aspects

Volumn 158, Issue 1-2, 1999, Pages 59-66

  Bermudez M ^a   Martinez, E ^a   Mora, M ^a   Sagrista M L ^a   De Madariaga, M A ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Drug lipid interactions; N acylated glicerophospholipids; Ofloxacin; Rifampicin; Tuberculostatics

Indexed keywords

DIFFERENTIAL SCANNING CALORIMETRY; DRUG INTERACTIONS; ELECTROSTATICS; LIPIDS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

LIPOSOMES; OFLOXACIN; RIFAMPICIN;

ANTIBIOTICS;

LIPOSOME; OFLOXACIN; RIFAMPICIN;

ARTICLE; CHEMICAL REACTION; DRUG FORMULATION; DRUG MIXTURE; LIPID BILAYER; MOLECULAR INTERACTION; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 0344117511     PISSN: 09277757     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0927-7757(99)00131-4     Document Type: Article

References (33)

1. Barenholz Y., Crommelin D.J.A. Swarbrick J., Boylan C. Encyclopedia of Pharmaceutical Technology. 9:1993;Marcel Dekker, New York.
2. Lasic D.D., Papahadjopoulos D. Science. 267:1995;1275.
3. Lasic D.D. Lasic D.D., Barenholz Y. Nonmedical Applications of Liposomes. 1:1996;CRC, Boca Raton. Chp. 1.
4. Betagesi G.V., Jenkins S.A., Parsons D.L. Liposome Drug Delivery Systems. 1993;Technomic, Lancaster. Chp. 2.
5. Gregoriadis G. J. Drug Target. 1:1993;3.
6. Monterez J.P., Van Bambeke F., Piret J., Schanck A., Brasseur R., Tulkens P.M., Mingeot-Leclercq M.P. Eur. J. Pharmacol. 314:1996;215.
7. Castelli F., Conti B., Macarrone D., La Camera O., Conte U. Drug Deliv. 4:1997;273.
8. Gicquand C., Auger M., Wong P.T.T., Poyer P., Boudreau N., Guadreault R.C. Arch. Biochem. Biophys. 334:1996;193.
9. Cheng H.Y., Randall C.S., Holl W.W., Coustantinides P.P., Yue T.L., Fenerstein G.Z. Biochim. Biophys. Acta. 1248:1996;20.
10. Pajeva I.K., Wiese M., Cordes H.P., Seydel J.K. J. Cancer Res. Clin. Oncol. 122:1996;27.
11. De Paula E., Schreier S. Braz. J. Med. Biol. Res. 29:1996;877.
12. Castelli F., Cambria M.T., Mazzone P., Pignatello R. Thermochim. Acta. 302:1997;143.
13. Lim L.Y., Go M.L. Chem. Pharm. Bull. 43:1995;2226.
14. Nie S.Q., Majarais I., Kwant C.Y., Epand R.N. Eur. J. Pharmacol. 266:1994;11.
15. Thomas P.G., Seelig J. Gómez-Ferández J.C., Chapman D., Packer L. Progress in Membrane Biotechnology. 1991;306 Birkhäuser Verlag, Basel.
16. Seydel J.K. TiBS. 12:1991;368.
17. Thomas P.G., Verkleij A.J. Biochim. Biophys. Acta. 1030:1990;211.
18. Mauromoustakos T., Theodoropoulou E., Polychroniou V., Dimitriou A., Koufaki M., Calageropoulou T. Epitheor. Klin. Farmakol. Farmakokinet. 13:1995;81.
19. Mayhew E., Ahmad I., Bhatia S., Dause R., Filep J., Janoff A.S., Kaisheva E., Perkins W.R., Zha Y., Franklin J.C. Bichim. Biophys. Acta. 1329:1997;139.
20. Deol P., khuller G.K., Joshi K. Antimicrob. Agents Chemother. 41:1997;1211.
21. Oh Y.K., Nix D.E., Straubinger R.M. Antimicrob. Agents Chemother. 39:1995;2104.
22. G. López-Berenstein, I.J. Fidler (Eds.), Liposomes in the therapy of infections, diseases and cancer: proceeding of a Ciba-Geigy-Squibb Colloquium, Alan R. Liss, New York, 1989.
23. Margalit R. Rosoff M. Vesicles. 62:1996;Marcel Dekker, New York. Chp. 13.
24. Deol P., Khuller G.K. Biochim. Biophys. Acta. 1334:1997;161.
25. Schreier H. Huang L. Journal of Liposome Research. 2:1992;145 Marcel Dekker, New York.
26. Allen T.M., Moase E.H. Adv. Drug Deliv. Rev. 21:1996;117.
27. Agarwal A., Kandpal H., Gupta H.P., Singh N.B., Gupta C.M. Antimicrob. Agents Chemother. 38:1994;588.
28. Domingo J.C., Mora M., De Madariaga M.A. Chem. Phys. Lipids. 69:1994;229.
29. Cevc G. Biochim. Biophys. Acta. 1031:1990;311.
30. Jones M.N. Adv. Colloid Interface Sci. 54:1995;93.
31. George J., Lewis R.N., McElhaney A.H. Biochem. Cell. Biol. 68:1990;161.
32. Rouser G., Fleischer S., Yamamoto A. Lipids. 5:1970;494.
33. Garcia A.M., Rosell F., Sagrista M.L., Mora M., De Madariaga M.A. Colloids Surf. 115:1996;73.